Form 4: Danaher Executive Julie A. Sawyer Montgomery Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


Executive Vice President Julie A. Sawyer Montgomery reports the acquisition of restricted stock units and employee stock options in Danaher Corp.

Summary

  • Julie A. Sawyer Montgomery, an Executive Vice President at Danaher Corp, filed a Form 4 with the SEC.
  • The filing reports the grant of 12,034 restricted stock units (RSUs) on March 1, 2025, which are payable solely in common stock.
  • One fourth of the RSUs vest annually over four years starting March 1, 2025.
  • Montgomery also received two employee stock option grants: 24,067 options and 34,381 options, both with an exercise price of $207.76.
  • For the 24,067 options, one half becomes exercisable on each of the third and fourth anniversaries of the grant date.
  • For the 34,381 options, one fourth becomes exercisable on each of the first, second, third and fourth anniversaries of the grant date.
  • Following these transactions, Montgomery beneficially owns 16,918 shares of common stock, 24,067 of one type of employee stock options and 34,381 of another type of employee stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating confidence in the executive and the company's future performance.

Positives

  • The grant of RSUs and stock options aligns the executive's interests with those of the shareholders.
  • The vesting schedules encourage long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.

Industry Context

Stock option and RSU grants are a common practice in executive compensation packages within publicly traded companies to incentivize performance and retain key personnel.

Comparison to Industry Standards

  • Danaher's executive compensation practices, including the use of stock options and RSUs, are generally in line with industry standards for large, publicly traded corporations.
  • Companies like Thermo Fisher Scientific (TMO) and Abbott Laboratories (ABT) also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • The equity grants align the executive's interests with those of shareholders, potentially driving long-term value creation.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/01/2025Date of grant for restricted stock units and employee stock options; vesting start date.
03/04/2025Date of Form 4 filing.
03/01/2035Expiration date for employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.